Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: August 2013

DURECT Corp. (DRRX) Video Chart for Monday, August 19, 2013

Posted on August 19, 2013 by MissionIR

DRRX made a solid move on Friday, but once again found resistance in the area of $1.33. The spike in volume and share price appreciation has the indications shifting back to bullish positions, putting the chart on radar to start … Continue reading →

Posted in Technical Analysis | Leave a comment

Seacoast Banking Corp. (SBCF) Joins National Association of Corporate Directors

Posted on August 19, 2013 by MissionIR

Bank holding company Seacoast Banking Corporation of Florida announced that it has joined the National Association of Corporate Directors (NACD) as full board members. NACD board members include Fortune 50 corporations, small- and mid-cap businesses, nonprofit organizations, and public and … Continue reading →

Posted in Small Cap News | Leave a comment

Retrophin, Inc. (RTRX) to Secure Development and Commercialization Rights on Promising New Autism, Schizophrenia Treatment

Posted on August 16, 2013 by MissionIR

Retrophin, the biopharma developer focused on debilitating and life-threatening neurological diseases in unmet and underserved categories, announced signing a deal today which grants the company a 120-day exclusivity window in which to negotiate a royalty-bearing U.S. license for the intellectual … Continue reading →

Posted in Small Cap News | Leave a comment

Cardica, Inc. (CRDC) Files FDA Marketing Clearance Application for MicroCutter XCHANGE 30

Posted on August 16, 2013 by MissionIR

Cardica announced it has filed regulatory documents with the U.S. Food and Drug Administration to obtain marketing clearance for the MicroCutter XCHANGE 30, a cutting and stapling device designed for use in multiple open and minimally invasive surgical procedures. The … Continue reading →

Posted in Small Cap News | Leave a comment

National Phase Approvals Granted in Ireland and the Netherlands for Apricus Biosciences’ (APRI) Vitaros

Posted on August 16, 2013 by MissionIR

Pharmaceutical company Apricus Biosciences announced that both the Irish Medicines Board and the Netherlands’ Medicines Evaluation Board have granted national phase approvals for Vitaros. Indicated to treat patients with erectile dysfunction, Vitaros is a topically applied cream formulation of alprostadil, … Continue reading →

Posted in Small Cap News | Leave a comment

SiriusXM Radio (SIRI) Enters Agreement to Acquire Connected Vehicle Unit of Agero

Posted on August 15, 2013 by MissionIR

Sirius XM Radio, the world’s largest radio broadcaster measured by revenue, featuring over than 25 million subscribers, announced today that it has reached a definitive agreement to acquire Agero for $530 million in cash. Agero is the leading provider of … Continue reading →

Posted in Small Cap News | Leave a comment

Applied Minerals, Inc. (AMNL) Continues Leadership in Applications of Naturally Occurring Nanotube Material, Halloysite Clay

Posted on August 14, 2013 by MissionIR

Applied Minerals, a global leader in niche applications of a unique aluminosilicate clay material that forms natural microscopic tubes known as Halloysite Clay, which the company obtains via its wholly-owned 230-acre Dragon Mine in Utah’s Tintic District (the only known … Continue reading →

Posted in Small Cap News | Leave a comment

Pluristem Therapeutics Inc. (PSTI) Reports Results of Pre-Clinical Trial of PLX Cells in Tendon Injury

Posted on August 14, 2013 by MissionIR

Pluristem Therapeutics is a leading developer of placenta-based cell therapies. Its patented PLX (PLacental eXpanded) cells are a drug delivery platform that releases a cocktail of therapeutic proteins to treat a number of ailments and diseases. The company has a … Continue reading →

Posted in Small Cap News | Leave a comment

Cardium Therapeutics, Inc. (CXM) Highlights Recent Achievements, Reports Q2 Sales Growth

Posted on August 14, 2013 by MissionIR

Cardium Therapeutics today presented recent highlights and other business developments while reporting its financial results for the second quarter ended June 30, 2013. The company said it now has four business units in its portfolio: Angionetics Biologics, which includes Cardium’s … Continue reading →

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Chanticleer Holdings, Inc. (HOTR) Signs Letter of Intent to Acquire American Roadside Burgers Chain

Posted on August 14, 2013 by MissionIR

Chanticleer Holdings, focused on expanding the Hooters® restaurant brand on an international scale, has signed a non-binding Letter Of Intent to purchase all of the outstanding shares of American Roadside Burgers, Inc. (ARB), a Charlotte, N.C.-based chain of five restaurants. … Continue reading →

Posted in Chanticleer Holdings Inc. HOTR, Small Cap News | Leave a comment